课题基金 / 基金详情

IVIG VERSUS PLACEBO IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY

IVIG VERSUS PLACEBO IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
IVIG 与安慰剂治疗慢性炎症性脱髓鞘性多发性神经病的比较
批准号：
6278738
负责人：
Richard J. Barohn
金额：
$2.47万
依托单位：
UT SOUTHWESTERN MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
1997
资助国家：
美国
项目状态：
已结题
起止时间：
1997-12-01 至 1998-11-30
来源：
https://reporter.nih.gov/project-details/6278738
关键词：
chronic disease /disorder clinical research clinical trials drug adverse effect electromyography functional ability human subject human therapy evaluation immunoglobulins immunotherapy intravenous administration muscle strength nervous system disorder placebos respiratory airway volume

项目摘要

项目成果

Richard J. Barohn的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This is a randomized, double-blind, controlled study designed to compare the response to treatment with IVIG versus placebo in previously untreated patients with chronic inflammatory demyelinating polyneuropathy(CIDP). The primary efficacy parameter is Muscle Strength Testing using the Average Muscle Score. Additional efficacy testing includes: Functional disability Scale, Handgrip Strength, Forced Vital Capacity, Timed Functional Tasks, and Electrophysiologic Measures of nerve conduction (EMG). Safety and tolerance will be evaluated as well.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Frontiers: University of Kansas Clinical and Translational Science Institute
Frontiers: University of Kansas Clinical and Translational Science Institute
Models of Neuromuscular Disease Across the Lifespan
A Phase II Trial of Rituximab In Myasthenia Gravis
  • 批准号：
    8644497
  • 项目类别：
  • 资助金额：
    $130.54万
  • 财政年份：
    2013
  • 负责人：
    Richard J. Barohn
  • 依托单位：
    YALE UNIVERSITY
海外基金